BioMedWire Stocks

Teens Suffering from Concussions Could Benefit from Screen Time

As mobile phones, social media and apps have taken center stage in our lives, several experts have become increasingly worried about the amount of time the average person spends looking at screens. On average, people around the world spend nearly seven hours daily on their screens, with the average American spending an average of seven hours and four minutes every day on their screens. Gen Z, the generation that grew up with the internet, spends up to nine hours per day looking at screens.

But while studies show that too much screen time can have negative effects on adolescents and children, recent research reveals that there are some instances where screen time can be beneficial. A study, which was published in “American Academy of Pediatrics, suggests that screen time can help teenagers who sustained concussions recover from their head injuries. Traditionally, experts recommend refraining from strenuous physical activity after a concussion and resting for a few days to speed up recovery.

Now, researchers from the University of Calgary and the University of British Columbia say that adding two to seven hours of screen time across different devices can aid in concussion recovery. The researchers analyzed 700 patients aged 8 to 16 after a concussion and found that those who had a moderate amount of screen time (two to seven hours) per day recovered from their head injuries faster. Molly Cairncross, PhD, an assistant professor from Simon Fraser University, said that devices include televisions, computers and mobile phones.

Of the patients surveyed for the study, those who had less than moderate screen time in the seven to ten days after injury reported experiencing more concussion symptoms, including fatigue and headaches throughout the first month compared to those who had moderate screen time.

However, both sets of patients reported nearly identical symptoms after the first month, indicating that screen time may have minimal impact on the long-term recovery of pediatric concussion patients.

This research is in direct contrast with a 2021 study carried out by University of Massachusetts Medical School researchers, which found that screen time slowed concussion recovery. In the 2021 study, concussion patients aged 12 to 25 who had zero screen time in the first 48 hours of recovery reported remarkably shorter symptom durations (three to five days) compared to those who did not abstain from screen time (eight days).

According to Cairncross, the opposing results of the two studies may be due to “differences in study design,” with the 2021 study measuring screen use of the first 48 hours and concussion recovery over 10 days while the recent study was more focused on screen time in the first seven to 10 days and followed patient recovery over a six-month period.

Autoimmune illnesses such as asthma are also ticking up in the pediatric and general population, and novel therapeutics are sorely needed to address this growing need. Entities such as BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) have projects in the pipeline geared at meeting this need.

NOTE TO INVESTORS: The latest news and updates relating to BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) are available in the company’s newsroom athttps://ibn.fm/BVXV

About BioMedWire

BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to millions of social media followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.

To receive SMS text alerts from BioMedWire, text “Biotech” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.biomedwire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
www.biomedwire.com
415.949.5050 Office
Editor@BioMedWire.com

BioMedWire is part of the InvestorBrandNetwork.

Chris@BMW

Share
Published by
Chris@BMW

Recent Posts

Study Finds That Marijuana Legalization Lowers Crime Rates

David Eby, the Premier of British Columbia, has revealed that a wide range of American healthcare workers,…

6 hours ago

Earth Science Tech Inc. (ETST) Builds Telehealth, Pharmacy Links in Evolving Digital Care

Patients increasingly prefer access, speed and convenience, but healthcare systems also need better coordination, safer…

1 day ago

Soligenix Inc. (NASDAQ: SNGX) Advances Rare Disease Innovation Through Platform Science and Expanding Therapeutic Pipeline

High-quality development platforms and translational research frameworks have become essential tools in rare-disease biotechnology. Soligenix…

1 day ago

Mirror-Image Amino Acid Shows Promise in Starving Cancer Cells

Most existing cancer treatments not only attack cancer cells but also adversely impact healthy body cells. The…

2 days ago

Investing in Innovation: Evaluating the Clinical and Commercial Potential of LB-100 and Liora’s Proton Therapy

LIXTE Biotechnology Holdings and Liora Technologies recently joined forces to soon offer a real fight…

3 days ago

Microbial Ecosystems Play a Big Role in the Efficacy of Cancer Immunotherapy

Significant strides have been made in leveraging checkpoint inhibitor therapy to combat a number of cancers over the recent…

6 days ago